These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8387567)

  • 21. Reconstitution of cytomegalovirus-specific T-cell response in allogeneic hematopoietic stem cell recipients: the contribution of six frequently recognized, virus-encoded ORFs.
    Nemeckova S; Krystofova J; Babiarova K; Hainz P; Musil J; Sroller V; Maly M; Stastna-Markova M
    Transpl Infect Dis; 2016 Jun; 18(3):381-9. PubMed ID: 27061389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative virulence and immunogenicity of the Towne strain and a nonattenuated strain of cytomegalovirus.
    Quinnan GV; Delery M; Rook AH; Frederick WR; Epstein JS; Manischewitz JF; Jackson L; Ramsey KM; Mittal K; Plotkin SA
    Ann Intern Med; 1984 Oct; 101(4):478-83. PubMed ID: 6089634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human cytomegalovirus proteins pp65 and immediate early protein 1 are common targets for CD8+ T cell responses in children with congenital or postnatal human cytomegalovirus infection.
    Gibson L; Piccinini G; Lilleri D; Revello MG; Wang Z; Markel S; Diamond DJ; Luzuriaga K
    J Immunol; 2004 Feb; 172(4):2256-64. PubMed ID: 14764694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant modified vaccinia virus Ankara expressing a soluble form of glycoprotein B causes durable immunity and neutralizing antibodies against multiple strains of human cytomegalovirus.
    Wang Z; La Rosa C; Maas R; Ly H; Brewer J; Mekhoubad S; Daftarian P; Longmate J; Britt WJ; Diamond DJ
    J Virol; 2004 Apr; 78(8):3965-76. PubMed ID: 15047812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ex vivo profiling of CD8+-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers.
    Elkington R; Walker S; Crough T; Menzies M; Tellam J; Bharadwaj M; Khanna R
    J Virol; 2003 May; 77(9):5226-40. PubMed ID: 12692225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Establishment and validation of an enzyme-linked immunosorbent assay for IgG antibody against cytomegalovirus based on pp150 antigen.
    Xi H; Jinjie L; Shengxiang G; Tingdong L; Han W; Xiaoyi G; Tong-Ming F; Jun Z
    J Virol Methods; 2017 Feb; 240():21-25. PubMed ID: 27825854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A CMV DNA vaccine primes for memory immune responses to live-attenuated CMV (Towne strain).
    Jacobson MA; Adler SP; Sinclair E; Black D; Smith A; Chu A; Moss RB; Wloch MK
    Vaccine; 2009 Mar; 27(10):1540-8. PubMed ID: 19168107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human cytomegalovirus (HCMV) infection/re-infection: development of a protective HCMV vaccine.
    Gerna G; Lilleri D
    New Microbiol; 2019 Jan; 42(1):1-20. PubMed ID: 30671581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A phase 1 study of 4 live, recombinant human cytomegalovirus Towne/Toledo chimeric vaccines.
    Heineman TC; Schleiss M; Bernstein DI; Spaete RR; Yan L; Duke G; Prichard M; Wang Z; Yan Q; Sharp MA; Klein N; Arvin AM; Kemble G
    J Infect Dis; 2006 May; 193(10):1350-60. PubMed ID: 16619181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of murine cytomegalovirus (MCMV) replication with a DNA vaccine encoding MCMV M84 (a homolog of human cytomegalovirus pp65).
    Morello CS; Cranmer LD; Spector DH
    J Virol; 2000 Apr; 74(8):3696-708. PubMed ID: 10729145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neutralization of Diverse Human Cytomegalovirus Strains Conferred by Antibodies Targeting Viral gH/gL/pUL128-131 Pentameric Complex.
    Ha S; Li F; Troutman MC; Freed DC; Tang A; Loughney JW; Wang D; Wang IM; Vlasak J; Nickle DC; Rustandi RR; Hamm M; DePhillips PA; Zhang N; McLellan JS; Zhu H; Adler SP; McVoy MA; An Z; Fu TM
    J Virol; 2017 Apr; 91(7):. PubMed ID: 28077654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of the proliferative T cell response to human cytomegalovirus major immediate-early protein (IE1): phenotype, frequency and variability.
    Davignon JL; Clément D; Alriquet J; Michelson S; Davrinche C
    Scand J Immunol; 1995 Mar; 41(3):247-55. PubMed ID: 7871384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitory effect of povidone-iodine for the antigen expression of human cytomegalovirus.
    Numazaki K; Asanuma H
    In Vivo; 1999; 13(3):239-41. PubMed ID: 10459499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical detection of an immediate early antigen of human cytomegalovirus in normal tissues.
    Toorkey CB; Carrigan DR
    J Infect Dis; 1989 Nov; 160(5):741-51. PubMed ID: 2553823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccination of pediatric nurses with live attenuated cytomegalovirus.
    Fleisher GR; Starr SE; Friedman HM; Plotkin SA
    Am J Dis Child; 1982 Apr; 136(4):294-6. PubMed ID: 6280490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of allergic aspermatogenesis with that induced by vasectomy. I. In vivo studies in the guinea-pig.
    Muir VY; Turk JL; Hanley HG
    Clin Exp Immunol; 1976 Apr; 24(1):72-80. PubMed ID: 949875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the T-cell response to human cytomegalovirus (HCMV) as detected by cytokine flow cytometry and QuantiFERON-CMV assay in HCMV-seropositive kidney transplant recipients.
    Gabanti E; Lilleri D; Scaramuzzi L; Zelini P; Rampino T; Gerna G
    New Microbiol; 2018 Jul; 41(3):195-202. PubMed ID: 30028473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictive value of human cytomegalovirus (HCMV) T-cell response in the control of HCMV infection by seropositive solid-organ transplant recipients according to different assays and stimuli.
    Gabanti E; Bruno F; Scaramuzzi L; Mangione F; Zelini P; Gerna G; Lilleri D
    New Microbiol; 2016 Oct; 39(4):247-258. PubMed ID: 27727404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human cytomegalovirus pp65- and immediate early 1 antigen-specific HLA class I-restricted cytotoxic T cell responses induced by cross-presentation of viral antigens.
    Tabi Z; Moutaftsi M; Borysiewicz LK
    J Immunol; 2001 May; 166(9):5695-703. PubMed ID: 11313411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Little role of anti-gB antibodies in neutralizing activity of patient's sera with human cytomegalovirus (HCMV) infection.
    Park JW; Kim DJ; Kim J; Park CG; Hwang ES; Cha CY
    J Korean Med Sci; 2000 Apr; 15(2):133-8. PubMed ID: 10803687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.